NO930035L - Eksitatoriske aminosyreantagonister - Google Patents

Eksitatoriske aminosyreantagonister

Info

Publication number
NO930035L
NO930035L NO93930035A NO930035A NO930035L NO 930035 L NO930035 L NO 930035L NO 93930035 A NO93930035 A NO 93930035A NO 930035 A NO930035 A NO 930035A NO 930035 L NO930035 L NO 930035L
Authority
NO
Norway
Prior art keywords
amino acid
acid antagonists
exitatory
exitatory amino
antagonists
Prior art date
Application number
NO93930035A
Other languages
English (en)
Other versions
NO179249C (no
NO930035D0 (no
NO179249B (no
Inventor
Francesco G Salituro
Bruce M Baron
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO930035D0 publication Critical patent/NO930035D0/no
Publication of NO930035L publication Critical patent/NO930035L/no
Publication of NO179249B publication Critical patent/NO179249B/no
Publication of NO179249C publication Critical patent/NO179249C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO930035A 1990-07-16 1993-01-07 Analogifremgangsmåte for fremstilling av terapeutisk aktive 4,6- disubstituerte 2,3-dikarboksylsyreindolderivater NO179249C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55605790A 1990-07-16 1990-07-16
PCT/US1991/004253 WO1992001670A1 (en) 1990-07-16 1991-06-17 Excitatory amino acid antagonists

Publications (4)

Publication Number Publication Date
NO930035D0 NO930035D0 (no) 1993-01-07
NO930035L true NO930035L (no) 1993-01-07
NO179249B NO179249B (no) 1996-05-28
NO179249C NO179249C (no) 1996-09-04

Family

ID=24219725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930035A NO179249C (no) 1990-07-16 1993-01-07 Analogifremgangsmåte for fremstilling av terapeutisk aktive 4,6- disubstituerte 2,3-dikarboksylsyreindolderivater

Country Status (15)

Country Link
US (1) US5106847A (no)
EP (1) EP0539503B1 (no)
JP (1) JP3058688B2 (no)
KR (1) KR0178469B1 (no)
AT (1) ATE136295T1 (no)
AU (1) AU646686B2 (no)
CA (1) CA2087091C (no)
DE (1) DE69118539T2 (no)
DK (1) DK0539503T3 (no)
ES (1) ES2088011T3 (no)
FI (1) FI98455C (no)
GR (1) GR3019689T3 (no)
HU (1) HU216787B (no)
NO (1) NO179249C (no)
WO (1) WO1992001670A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189054A (en) * 1990-11-02 1993-02-23 Merrell Dow Pharmaceuticals Inc. 3-amidoindolyl derivatives and pharmaceutical compositions thereof
US5318985A (en) * 1991-12-20 1994-06-07 Merrell Dow Pharmaceuticals Inc. Potentiation of NMDA antagonists
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
TW280819B (no) * 1993-11-17 1996-07-11 Sumitomo Pharma
US5696148A (en) * 1994-03-14 1997-12-09 Novo Nordisk A/S Indole compounds and their use in treating diseases of the central nervous system
US5783575A (en) * 1994-03-14 1998-07-21 Novo Nordisk A/S Antagonists, their preparation and use
US5563157B1 (en) * 1994-10-31 1999-02-02 Hoecst Marion Roussel Inc Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
WO1997005109A1 (en) * 1995-07-31 1997-02-13 Novo Nordisk A/S Heterocyclic compounds, their preparation and use
WO1998014427A1 (en) * 1996-09-30 1998-04-09 Hoechst Marion Roussel, Inc. Nmda (n-methyl-d-aspartate) antagonists
JP4467648B2 (ja) 1997-03-14 2010-05-26 スミスクライン・ビーチャム・コーポレイション 新規インドールカルボキサミド、医薬組成物およびカルパインの阻害方法
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
JP2005506292A (ja) * 2001-03-08 2005-03-03 エモリー　ユニバーシティ ｐＨに依存するＮＭＤＡレセプターアンタゴニスト
WO2003039540A2 (en) * 2001-11-09 2003-05-15 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
CN103497114A (zh) 2007-06-29 2014-01-08 埃莫里大学 用于神经保护的nmda受体拮抗剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
JPH0347123A (ja) * 1989-05-05 1991-02-28 G D Searle & Co インドール―２―カルボキシレート化合物類を含有するｃｎｓ疾患治療用組成物
EP0548250B1 (en) * 1990-09-10 1996-03-27 Rhone-Poulenc Rorer International (Holdings) Inc. Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
WO1993005020A1 (en) * 1991-09-06 1993-03-18 Merck & Co., Inc. Indoles as inhibitors of hiv reverse transcriptase

Also Published As

Publication number Publication date
HU9300100D0 (en) 1993-04-28
DE69118539T2 (de) 1996-09-19
DE69118539D1 (de) 1996-05-09
WO1992001670A1 (en) 1992-02-06
KR0178469B1 (ko) 1999-03-20
ES2088011T3 (es) 1996-08-01
FI930150A0 (fi) 1993-01-14
JPH05508857A (ja) 1993-12-09
EP0539503B1 (en) 1996-04-03
AU8290891A (en) 1992-02-18
US5106847A (en) 1992-04-21
EP0539503A1 (en) 1993-05-05
FI930150L (fi) 1993-01-14
NO179249C (no) 1996-09-04
FI98455B (fi) 1997-03-14
GR3019689T3 (en) 1996-07-31
DK0539503T3 (da) 1996-05-13
AU646686B2 (en) 1994-03-03
CA2087091A1 (en) 1992-01-17
HUT67237A (en) 1995-03-28
HU216787B (hu) 1999-08-30
NO930035D0 (no) 1993-01-07
FI98455C (fi) 1997-06-25
EP0539503A4 (no) 1994-03-23
CA2087091C (en) 2001-09-11
NO179249B (no) 1996-05-28
ATE136295T1 (de) 1996-04-15
JP3058688B2 (ja) 2000-07-04

Similar Documents

Publication Publication Date Title
NO930035D0 (no) Eksitatoriske aminosyreantagonister
FI961628A0 (fi) Indolijohdannaisia NMDA-antagonisteina
DE69127755D1 (de) Okulare hypotensive 2-dekarboxyl-2-aminoalkyl-prostaglandine
DK0526478T3 (da) 3-Indolyl-thioacetat-derivater
CZ282732B6 (cs) Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv
ATE168103T1 (de) Cholecystokininantagoniste
DE69230224D1 (de) Potenzierung von nmda-antagonisten
ATE137225T1 (de) Dihydrochinolin nmda antagonisten
GR1001309B (el) Μεθοδος παρασκευης παραγωγου ενωσεως της διχλωροανιλινης.
NO911916D0 (no) Fremgangsmaate for fremstilling av heterocykliske nmda-antagonister.
CZ281393B6 (cs) Způsob výroby 6-(substituovaných amino)-propionyl derivátů forskolinu
ES2067417B1 (es) Procedimiento para preparar nuevos derivados en n de (feniletil-beta-ol)-amina.